DNMT1 and neoplasm: For example, it has been found that histone deacetylation (HDAC) inhibitors and DNA methyltransferase (DNMT) inhibitors can induce immunogenic cell death and promote tumor cell antigen presentation, MHC-I expression, and tumor-specific antigen production [191, 192].